Company Overview of University of California - San Diego
University of California - San Diego is an educational institution that offers undergraduate and graduate courses in Aerospace Engineering, Anthropology, Bioengineering, Computer Science & Engineering, Economics, History, Literature, and Music. The University has six colleges that include Thurgood Marshall, John Muir, Revelle, Roosevelt, Sixth, and Warren College. University of California - San Diego has endowment assets of $274 millions.
9500 Gilman Drive
La Jolla, CA 92093
Founded in 2007
Key Executives for University of California - San Diego
Associate Vice Chancellor
Vice Chancellor of Research
Chief of the Division of Global Public Health, Associate Dean for Global Health Sciences, Co-Head of Center of Expertise on Migration and Health and Director of the Global Health Initiative
Director of Communications
Compensation as of Fiscal Year 2015.
University of California - San Diego Key Developments
TowerJazz and the University of California, San Diego Announces the Collaboration to Demonstrate the First 256-Element (16 X 16) Wafer-Scale Phased Array Transmitter
May 14 15
TowerJazz and The University of California, San Diego (UCSD), announced they have collaborated to demonstrate the first 256-element (16 x 16) wafer-scale phased array transmitter with integrated high-efficiency antennas operating at 56-65 GHz frequency range. In addition, TowerJazz proprietary methods allowed for very large chip area with an extremely high level of integration. The phased-array system-on-a-chip (SoC) targets the emerging 5G high-performance wireless standard which will aim for greater than 10 Gbps (gigabits per second) peak data-rate communication. The array has beamforming capabilities that include independent amplitude and phase control for all 256 different antenna elements. By developing this wafer-scale chip, UCSD and TowerJazz have successfully demonstrated highly scalable RF-IC transmitters for 5G phased array applications. The collaboration of the wafer-scale phased array chip was partially funded through collaboration with DARPA. Phased arrays allow the electronic steering of an antenna beam in any direction and with high antenna gain by controlling the phase at each antenna element. The radiation beam can be moved in space using entirely electronic means through control of the phase and amplitude at each antenna element used to generate the beam. This beam steering technique is much more compact and much faster than mechanically steered arrays. Furthermore, phased arrays allow the creation of deep nulls in the radiation pattern to mitigate strong interference signals from several different directions. They have been in use since the 1950s in defense applications and have seen limited use in commercial systems due to their relatively high cost. UCSD’s design and utilization of TowerJazz wafer processes are targeted to greatly reduce the cost of phased arrays especially at millimeter-wave frequencies for 5G communication systems.
University of California San Diego and University of California San Francisco Launch New Cancer Cell Mapping Initiative
Jan 29 15
Researchers from the University of California, San Diego School of Medicine and University of California, San Francisco, with support from a diverse team of collaborators, have launched an ambitious new project - dubbed the Cancer Cell Map Initiative or CCMI - to determine how all of the components of a cancer cell interact. In recent years, progress in genome sequencing has made it possible to decipher hundreds of mutations found in a patient's tumor. But in only a few cases do scientists understand how these mutations give rise to cancer or indicate what treatments to pursue. More puzzling still, the mutations found in each patient are almost always different - even though they can lead to the same type of cancer. It has long been thought that, while these mutations are unique to individuals, they hijack the same hallmark cancer pathways or genetic circuits. To interpret genomic data, researchers say the complete wiring diagram of the cell is needed, one that details all of the connections between normal and mutated genes and proteins. The CCMI will provide key infrastructure for the recently announced alliance between UC San Diego Health Sciences and San Diego-based Human Longevity Inc., which plans to generate thousands of tumor genomes from UC San Diego cancer patients. It will also leverage resources and information from the National Cancer Institute (NCI), including large databases of cancer genomes and pathways that are being developed in collaboration with the San Diego Supercomputer Center and UC Santa Cruz.
Trovagene Collaborates with University of california San Diego Moores Cancer Center to Demonstrate Clinical Utility of Detecting and Monitoring EGFR Mutations in Lung Cancer Patients
Jan 12 15
Trovagene, Inc. announced that it has entered into a clinical collaboration with University of California, San Diego Moores Cancer Center to determine the utility of detecting and monitoring EGFR mutations, using its Precision Cancer MonitoringSM platform. This large-scale study expands on the company's clinical programs in lung cancer at Memorial Sloan Kettering Cancer Center and City of Hope Medical Center. Lung cancer is the leading cause of cancer mortality worldwide, and Trovagene is focused on providing an improved solution for the detection and monitoring of EGFR mutations in lung cancer patients.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|